Magro G, Bisceglia M, Michal M
Istituto di Anatomia Patologica, Universitá di Catania, Italy.
Histopathology. 2000 Jun;36(6):515-21. doi: 10.1046/j.1365-2559.2000.00907.x.
To investigate the possible role of steroid hormones in the pathogenesis of myofibroblastoma (MFB) of the breast, we analysed the immunohistochemical expression of oestrogen, progesterone, androgen receptors, their regulated proteins and bcl-2 protein in a series of this rare tumour.
Paraffin-embedded sections from seven cases of MFB of the breast (five male; two female) were immunohistochemically tested for the expression of oestrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR), oestrogen-regulated pS2 protein, androgen-regulated prostate-specific antigen (PSA) and bcl-2 protein. Rare cases of benign spindle cell tumours or tumour-like lesions of the breast (primitive fibromatosis, inflammatory pseudotumour, muscular hamartoma) which enter into the differential diagnosis with MFB, were also investigated and compared with MFB. All cases of MFB showed a diffuse (70-90% of neoplastic cells) and strong nuclear labelling with ER and PR, whereas AR was expressed only in three cases (two men and one woman) in about 60-70% of cells. Conversely, no immunostaining was detected for the pS2 protein and PSA. bcl-2 protein immunoreactivity was found in all cases of MFB, although with a variable degree of expression. No expression for steroid hormone receptors, their regulated-proteins and bcl-2 protein was observed in the rare benign spindle cell lesions of the breast included in this study.
The in-situ detection of ER, PR and AR suggests that steroid hormones and their receptors are implicated in the pathogenesis of breast MFB. The consistent demonstration of bcl-2 protein, associated with a positive ER/PR status, provides evidence that bcl-2 may be an oestrogen-regulated protein also in MFB and that probably plays a role in the tumorigenesis. Finally, we postulate that the ER/PR and bcl-2 positive immunoprofile of MFB of the breast, in contrast to the negative profile of other rare primitive benign spindle cell lesions of the breast herein studied, might be exploited as an ancillary diagnostic aid in differential diagnosis of doubtful cases.
为研究类固醇激素在乳腺肌纤维母细胞瘤(MFB)发病机制中的可能作用,我们分析了一系列这种罕见肿瘤中雌激素、孕激素、雄激素受体、其调节蛋白和bcl-2蛋白的免疫组化表达情况。
对7例乳腺MFB(5例男性;2例女性)的石蜡包埋切片进行免疫组化检测,以检测雌激素受体(ER)、孕激素受体(PR)、雄激素受体(AR)、雌激素调节的pS2蛋白、雄激素调节的前列腺特异性抗原(PSA)和bcl-2蛋白的表达。还对与MFB进行鉴别诊断的罕见乳腺良性梭形细胞瘤或肿瘤样病变(原始纤维瘤病、炎性假瘤、肌肉错构瘤)进行了研究,并与MFB进行比较。所有MFB病例均显示ER和PR呈弥漫性(占肿瘤细胞的70 - 90%)且强核染色,而AR仅在3例(2例男性和1例女性)中约60 - 70%的细胞中表达。相反,未检测到pS2蛋白和PSA的免疫染色。在所有MFB病例中均发现bcl-2蛋白免疫反应性,尽管表达程度有所不同。在本研究纳入的罕见乳腺良性梭形细胞病变中未观察到类固醇激素受体、其调节蛋白和bcl-2蛋白的表达。
ER、PR和AR的原位检测表明类固醇激素及其受体与乳腺MFB的发病机制有关。bcl-2蛋白的一致显示,与ER/PR阳性状态相关,提供了证据表明bcl-2在MFB中也可能是一种雌激素调节蛋白,并且可能在肿瘤发生中起作用。最后,我们推测乳腺MFB的ER/PR和bcl-2阳性免疫表型,与本文研究的其他罕见原始良性乳腺梭形细胞病变的阴性表型相反,可作为可疑病例鉴别诊断的辅助诊断手段。